Command Palette

Search for a command to run...

POLYMED

₹1955.2+2.12%

Market Cap
₹19,794.49 Cr
Stock P/E
55.35
ROCE
20.37%
ROE
16.01%
Book Value
₹281.69

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

Poly Medicure Announces PendraCare Group Acquisition

Other Updates
1 month ago

Poly Medicure Announces PendraCare Group Acquisition

Other Updates
1 month ago

Poly Medicure shares in focus on acquisition of Netherlands based company

Other Updates
2 months ago

Shareholding

Holdings
Distribution
Promoter
Foreign Investors
Domestic Investors
Public

From Last Concall

POSITIVES
  • •
    Strong quarterly performance with solid gross margins and EBITDA efficiency driven by higher-margin newer products.
  • •
    Domestic revenue growth remains a key driver, expanding the company’s footprint and reducing reliance on government segments.
NEGATIVES
  • •
    International business faced near-term headwinds, with overall international revenue down modestly and Europe showing weakness.
  • •
    Guidance for international growth has been tempered due to current macro conditions, indicating a potential slower international growth trajectory.

Peers Summary

Sector Leader

Poly Medicure Ltd. stands out in the medical equipment sector with solid revenue growth and profitability metrics compared to its peers, indicating strong operational efficiency and a favorable market position. While some peers show high valuations with low growth, Poly Medicure presents a balanced combination of growth and profitability, making it a compelling investment opportunity.

Key Points
  • • Poly Medicure Ltd. has the highest revenue growth (YoY) at 21.37%.
  • • Laxmi Dental Ltd. has the highest ROE at 96.95%, but is overvalued with a PE of 100.52.
  • • Nureca Ltd. shows financial stress with negative EPS and high PEG ratio.
  • • Prevest Denpro Ltd. is a deep value pick due to its low PE and strong ROCE without debt.
Top Performers
Poly Medicure Ltd.

Highest revenue growth (21.37% YoY) and strong profitability with ROE at 16.01%.

Prevest Denpro Ltd.

Good ROCE (25.24%) and no debt, indicating financial stability despite low growth.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.

Explore
Watchlists